pubmed-article:16970952 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16970952 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16970952 | lifeskim:mentions | umls-concept:C0030274 | lld:lifeskim |
pubmed-article:16970952 | lifeskim:mentions | umls-concept:C0005330 | lld:lifeskim |
pubmed-article:16970952 | lifeskim:mentions | umls-concept:C0021655 | lld:lifeskim |
pubmed-article:16970952 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
pubmed-article:16970952 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
pubmed-article:16970952 | lifeskim:mentions | umls-concept:C0023983 | lld:lifeskim |
pubmed-article:16970952 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:16970952 | pubmed:dateCreated | 2007-10-23 | lld:pubmed |
pubmed-article:16970952 | pubmed:abstractText | Development of insulin resistance (IR) and the progressive failure of the pancreatic beta-cell function (BCF) may be important in the pathogenesis of type 2 diabetes. Influence of peroxisome proliferator-activated receptors ligand bezafibrate on BCF and IR in patients with diabetes is unknown. The present study was aimed to investigate the long-term effect of bezafibrate on these parameters in diabetic patients enrolled in the Bezafibrate Infarction Prevention (BIP) Study. | lld:pubmed |
pubmed-article:16970952 | pubmed:language | eng | lld:pubmed |
pubmed-article:16970952 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16970952 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16970952 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16970952 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16970952 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16970952 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16970952 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16970952 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16970952 | pubmed:month | Sep | lld:pubmed |
pubmed-article:16970952 | pubmed:issn | 1879-1484 | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:TanneDavidD | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:BoykoValentin... | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:AdlerYehudaY | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:BeharSolomonS | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:MotroMichaelM | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:TenenbaumAlex... | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:FismanEnrique... | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:MatasZiporaZ | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:Schwammenthal... | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:TenenbaumHele... | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:LapidotMordec... | lld:pubmed |
pubmed-article:16970952 | pubmed:author | pubmed-author:FeinbergMicha... | lld:pubmed |
pubmed-article:16970952 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16970952 | pubmed:volume | 194 | lld:pubmed |
pubmed-article:16970952 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16970952 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16970952 | pubmed:pagination | 265-71 | lld:pubmed |
pubmed-article:16970952 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:meshHeading | pubmed-meshheading:16970952... | lld:pubmed |
pubmed-article:16970952 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:16970952 | pubmed:articleTitle | Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes. | lld:pubmed |
pubmed-article:16970952 | pubmed:affiliation | Endocrinology and Diabetes Unit, Dan-Petah-Tikva District, Clalit Health Services, Israel. | lld:pubmed |
pubmed-article:16970952 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16970952 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16970952 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16970952 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16970952 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16970952 | lld:pubmed |